Left ventricular mechanical dyssynchrony as assessed by phase analysis of ECG-gated SPECT myocardial perfusion imaging

Echocardiography

Volumn 25, Issue 10, 2008, Pages 1186-1194

  Chen, Ji ^a   Garcia, Ernest V ^a   Lerakis, Stamatios ^a   Henneman, Maureen M ^b   Bax, Jeroen J ^b   Trimble, Mark A ^c   Borges Neto, Salvador ^c   Velazquez, Eric J ^c   Iskandrian, Ami E ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cardiac resynchronization therapy; Gated SPECT; Heart failure; Left ventricular dyssynchrony; Myocardial perfusion imaging

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FOURIER TRANSFORMATION; HEART CYCLE; HEART DISEASE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MECHANICAL DYSSYNCHRONY; HEART LEFT VENTRICLE WALL; HEART MUSCLE PERFUSION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 54849434226     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2008.00782.x     Document Type: Review

References (45)

1. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report from the ACC/AHA task force on practice guidelines writing committee to update the 2001 guidelines for the evaluation and management of heart failure. J Am Coll Cardiol 2005 46 : 1 82.
2. American Heart Association. Heart Disease and Stroke Statistics: 2006 Update. Dallas, TX, American Heart Association, 2006.
3. Leclercq C, Kass DA : Retiming the failing heart: Principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002 39 : 194 201.
4. Abraham WT, Hayes DL : Cardiac resynchronization therapy for heart failure. Circulation 2003 108 : 2596 2603.
5. Leclercq C, Hare JM : Ventricular resynchronization: Current state of the art. Circulation 2004 109 : 296 299.
6. Auricchio A, Stellbrink C, Block M, et al : Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999 99 : 2993 3001.
7. Brecker SJ, Xiao HB, Sparrow J, et al : Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992 340 : 1308 1312.
8. Leclercq C, Faris O, Tunin R, et al : Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002 106 : 1760 1763.
9. Achilli A, Sassara M, Ficili S, et al : Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 2003 42 : 2117 2124.
10. Bax JJ, Bleeker GB, Marwick TH, et al : Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004 44 : 1834 1840.
11. Bax JJ, Marwick TH, Molhoek SG, et al : Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003 92 : 1238 1240.
12. Gessner M, Gruska M, Blazek G, et al : Ventricular inter- and left ventricular intra ventricular systolic asynchrony in patients with dilated cardiomyopathy and the effect of cardiac resynchronization therapy. Echocardiography 2004 21 : 105.
13. Ghio S : Results of the predictors of response to CRT (PROSPECT) trial (ABSTRACT). European Society of Cardiology Congress 2007, Vienna, Austria.
14. Chen J, Garcia EV, Folks RD, et al : Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: Development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 2005 12 : 687 695.
15. Bleeker GB, Kaandorp TA, Lamb HJ, et al : Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006 113 : 969 976.
16. Gheorghiade M, Bonow RO : Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998 97 : 282 289.
17. Cohn JN, Archibald DG, Ziesche S, et al : Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative study. N Engl J Med 1986 314 : 1547 1552.
18. Cohn JN, Johnson G, Ziesche S, et al : A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991 325 : 303 310.
19. The CONSENSUS Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival study. N Engl J Med 1987 316 : 1429 1435.
20. DiBianco R, Shabetai R, Kostuk W, et al. for the Milrinone Multicenter Trial Group : A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989 320 : 677 683.
21. The Digitalis Investigation Group : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 336 : 525 533.
22. Feldman AM, Bristow MR, Parmley WW, et al. for the Vesnarinone Study Group : Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993 329 : 149 155.
23. Packer M, Carver JR, Rodeheffer RJ, et al. for the PROMISE Study Research Group : Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991 325 : 1468 1475.
24. Packer M, Gheorghiade M, Young JB, et al. for the RADIANCE Study Group : Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993 329 : 1 7.
25. Packer M, Bristow MR, Cohn JN, et al. for the U.S. Carvedilol Heart Failure Study Group : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 334 : 1349 1355.
26. Packer M, O'Connor CM, Ghali JK, et al. for the Amlodipine Survival Evaluation Study Group : Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996 335 : 1107 1114.
27. Singh SN, Fletcher RD, Fisher SG, et al. for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure : Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995 333 : 77 82.
28. The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991 325 : 293 302.
29. The SOLVD Investigators : Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992 327 : 685 691.
30. Bart BA, Shaw LK, McCants CB Jr., et al : Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997 30 : 1002 1008.
31. Garcia EV, DePuey EG, Sonnemaker RE, et al : Quantification of the reversibility of stress induced SPECT thallium-201 myocardial perfusion defects: A multicenter trial using Bull's-eye polar maps and standard normal limits. J Nucl Med 1990 31 : 1761 1765.
32. Faber TL, Cooke CD, Folks RD, et al : Left ventricular function and perfusion from gated spect perfusion images: An integrated method. J Nucl Med 1999 40 : 650 659.
33. Garcia EV, Faber TL, Cooke CD, et al : The increasing role of quantification in clinical nuclear cardiology. J Nucl Cardiol 2007 14 : 420 432.
34. Galt JR, Garcia EV, Robbins WL : Effects of myocardial wall thickness on SPECT quantification. IEEE Trans Med Imaging 1990 9 : 144 150.
35. Cooke CD, Garcia EV, Cullom SJ, et al : Determining the accuracy of calculating systolic wall thickening using a Fast Fourier Transform approximation: A simulation study based on canine and patient data. J Nucl Med 1994 35 : 1185 1192.
36. Yu CM, Chau E, Sanderson JE, et al : Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002 105 : 438 445.
37. Sogaard P, Egeblad H, Kim WY, et al : Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002 40 : 723 730.
38. Henneman MM, Chen J, Ypenburg C, et al : Phase analysis of gated myocardial perfusion SPECT compared to tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007 49 : 1708 1714.
39. Yu CM, Zhang Q, Fung JW, et al : A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 2005 45 : 677 684.
40. Yu CM, Fung WH, Lin H, et al : Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003 91 : 684 688.
41. Ajmone Marsan N, Henneman MM, Chen J, et al : Left ventricular dyssynchrony assessed by two 3-dimensional imaging modalities: Phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging. Eur J Nucl Med Mol Imaging 2008 35 : 166 173.
42. Trimble MA, Smalheiser S, Bornes-neto S, et al : Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol 2007 14 : 298 307.
43. Henneman MM, Chen J, Dibbets P, et al : Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 2007 48 : 1104 1111.
44. Trimble MA, Velazquez EJ, Adams GL, et al : Repeatability and reproducibility of phase analysis of gated SPECT myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun 2008 29 : 374 381.
45. Chen J, Faber TL, Cooke CD, et al : Temporal resolution of multi-harmonic phase analysis of ECG-gated myocardial perfusion SPECT studies. J Nucl Cardiol 2008 15 : 383 391.